Cosmegen (RECORDATI RARE DISEASES, INC.)


Welcome to the PulseAid listing for the Cosmegen drug offered from RECORDATI RARE DISEASES, INC.. This Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: RECORDATI RARE DISEASES, INC.
NON-PROPRIETARY NAME: dactinomycin
SUBSTANCE NAME: DACTINOMYCIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1964-12-10
END MARKETING DATE: 0000-00-00


Cosmegen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCosmegen from RECORDATI RARE DISEASES, INC.
LABELER NAME: RECORDATI RARE DISEASES, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/mL)
START MARKETING DATE: 1964-12-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55292-811_dcbf4425-ab68-edcf-9b16-3ac62668150d
PRODUCT NDC: 55292-811
APPLICATION NUMBER: NDA050682

Other DACTINOMYCIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RECORDATI RARE DISEASES, INC.Cosmegen